Condition: Schizophrenia;Schizoaffective · Sponsor: Centre for Addiction and Mental Health
This study seeks to explore the effects of transcranial direct current stimulation (tDCS), a non-invasive method of brain stimulation, as an adjunctive treatment to improve antipsychotic medication adherence in patients with schizophrenia (SCZ). The investigators hypothesize that 20 sessions of tDCS will improve medication nonadherence in patients with SCZ.
This description comes directly from the study's public registry record.
Philip Gerretsen, MD, PhD · 416-535-8501 · philip.gerretsen@camh.ca
Ariel Graff, MD, PhD · 416-535-8501 · ariel.graff@camh.ca
Always discuss trial participation with your own doctor first.
| Centre for Addiction and Mental Health | Toronto, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04033679